Recombinant APP (Donanemab Biosimilar) 抗体
This anti-APP (Donanemab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting APP (Donanemab Biosimilar) in ELISA 和 WB. Suitable for 人.
产品编号 ABIN7488202
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant APP (Donanemab Biosimilar) 抗体 (ABIN7488202)
抗原
APP (Donanemab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This APP (Donanemab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Donanemab Biosimilar - Anti-APP mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- APP (Donanemab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
LY3002813
Donanemab is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research.
抗原
-
You are here:
